Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review

Finasteride and dutasteride are 5-alpha reductase selective inhibitors (5ARIs). They were introduced as therapeutic agents for the treatment of benign prostatic hyperplasia in 1992 and 2002, respectively; finasteride has also been approved for the treatment of androgenetic alopecia since early 2000....

Descripción completa

Detalles Bibliográficos
Autores principales: Escamilla-Cruz, Mariana, Magaña, Mario, Escandón-Perez, Sabrina, Bello-Chavolla, Omar Yaxmehen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366043/
https://www.ncbi.nlm.nih.gov/pubmed/37432644
http://dx.doi.org/10.1007/s13555-023-00974-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366043/
https://www.ncbi.nlm.nih.gov/pubmed/37432644
http://dx.doi.org/10.1007/s13555-023-00974-4

Ejemplares similares